CAS: 169287-69-8; 2-(2-(((Benzyloxy)Carbonyl)Amino)-6-Oxo-3H-Purin-9(6H)-yl)Acetic Acid

该化合物是一种纯酸化合物,其成分为苯氧基碳基(Cbz)保护组和一个碳酸的功能,其结构使它成为有机合成中的宝贵中间体,特别是在制作核素类比和改良纯衍生物方面.Cbz组加强了合成操纵过程中的稳定性,而碳箱酸混合物允许通过配对或同源反应进一步实现功能化.该化合物对药用化学研究很感兴趣,因为它可以作为针对核相关途径的生物活性分子的前体.其定义明确的再活性特征和与标准联产条件的兼容性有助于其在复杂的分子构造中的用途.

结构式图片

相似化合物

1028077-12-4 172405-20-8 169287-79-0

上下游产品

[2-(benzyloxycarbonyl)-amino-6-iodopurin-9-yl]-acetic acid [[2-(2-Benzyloxycarbonylamino-6-oxo-1,6-dihydro-purin-9-yl)-acetyl]-((1S,2S)-2-tert-butoxycarbonylamino-cyclohexyl)-amino]-acetic acid ethyl ester Z)-OHB°C-PNA(GZ)-OH tert-butyl ester{(2-allyloxycarbonylamino-benzyl)-[(2-benzyloxycarbonylamino-6-oxo-1,6-dihydro-purin-9-yl)-acetyl]-amino}-acetic acid tert-butyl ester tert-butoxycarbonylamino-propyl)-[(2-benzyloxycarbonylamino-6-oxo-1,6-dihydro-purin-9-yl)-acetyl]-amino}-acetic acid ethyl ester{(3-benzyloxy-2-tert-butoxycarbonylamino-propyl)-[(2-benzyloxycarbonylamino-6-oxo-1,6-dihydro-purin-9-yl)-acetyl]-amino}-acetic acid ethyl ester

合成工艺路线路线简述

    📜Tert-Butyl (6-Chloro-9H-Purin-2-yl)Carbamate置于甲酸,Sodium Hydride,Potassium Carbonate体系中,用 四氢呋喃,水,N,N-二甲基甲酰胺,Mineral Oil 用作溶剂,化学反应 10.5H,反应生成1,6-二氢-6-氧代-2-[[(苯甲氧基)羰基]氨基]-9H-嘌呤-9-乙酸
    参考文献:开发方便的路线,以制备boc介导的pna合成所需的n 2-Cbz保护的鸟苷基合成子
    标题:开发方便的路线,以制备boc介导的pna合成所需的n 2-Cbz保护的鸟苷基合成子
    摘要:已经开发了一种高效,高产,化学和区域选择性的五步合成n 2-Cbz-鸟嘌呤-9-基乙酸的合成路线,该路线避免了使用三光气.在形成后ñ 2-Boc由2-氨基-6-氯嘌呤保护嘌呤,两个连续的基控制烷基化允许一个ñ 9-叔丁基乙酸酯功能后跟ñ 2-Cbz部分进行安装.通过对6-(2-硝基苯氧基)类似物的x射线晶体学研究证实了这些反应的选择性.最后水解脱氯并去除boc和叔叔同时在酸性条件下完成叔丁酯保护基团,以总产率53%得到鸟嘌呤-9-基pna单体合成子.
    Doi:10.1016/j.Tetlet.2013.09.034

    海关参考信息

    专利信息


    专利号:US-6172226-B1
    优先权日:1993-12-22
    标 题:Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
    发明人:COULL JAMES M; EGHOLM MICHAEL; HODGE RICHARD P; ISMAIL MOHAMED; RAJUR S B
    权利人:PERSEPTIVE BIOSYSTEMS INC
    摘要:A method is disclosed for preparing novel PNA synthons having protecting groups capable of removal under mild conditions. The PNA synthons are prepared by coupling novel N-substituted nucleobase intermediates having carbamate protection of the exocyclic amino group of the heterocycle to an amino protected backbone or an amino protected backbone ester of the amino acid N-(2-aminoethyl)-glycine. By the method of this invention, the resultant PNA synthons can have orthogonal protection of the carbamate protected nucleobase and the amino protected backbone. The PNA synthons are useful in the synthesis of peptide nucleic acids (PNAs) and other oligomers such as PNA-DNA chimeras, and may be used in automated synthesizers. Novel compositions of matter are also disclosed. In addition, a guanine PNA synthon having selective carbamate protection of the exocyclic 2-amino group with the C6 carbonyl group unprotected is disclosed.

    专利号:US-7411065-B2
    优先权日:2002-04-26
    标 题 :PNA monomer and precursor
    发明人:KIM SUNG KEE; LEE HYUNIL; LIM JONG CHAN; CHOI HOON; JEON JAE HOON; AHN SANG YOUL; LEE SUNG HEE; YOON WON JUN
    权利人:PANAGENE INC
    摘要:This application relates to monomers of the general formula (I) for the preparation of PNA (peptide nucleic acid) oglimers and provides method for the synthesis of both predefined sequence PNA oligomers and random sequence PNA oligomers: n nwhereinn E is nitrogen or C—R′; J is sulfur or oxygen; R′, R1, R2, R3, R4 is independently H, halogen, alkyl, nitro, nitrile, alkoxy, halogenated alkyl, halogenated alkoxy, phenyl or halogenated phenyl, R5 is H or protected or unprotected side chain of natural or unnatural α-amino acid; and B is a natural or unnatural nucleobase, wherein when said nucleobase has an exocyclic amino function, said function is protected by protecting group which is labile to acids but stable to weak to medium bases in the presence of thiol.

    专利号:US-7022851-B2
    优先权日:2002-01-24
    标题 :PNA monomer and precursor
    发明人:KIM SUNG KEE; LEE HYUNIL; LIM JONG CHAN; CHOI HOON; JEON JAE HOON; AHN SANG YOUL; LEE SUNG HEE
    权利人:PANAGENE INC
    摘要:This application relates to monomers of the general formula (I) for the preparation of PNA (peptide nucleic acid) oligomers and provides method for the synthesis of both predefined sequence PNA oligomers and random sequence PNA oligomers: n nwhereinn R1, R2, R3, R4, R5 is independently H, halogen, C 1 –C 4 alkyl, nitro, nitrile, C 1 –C 4 alkoxy, halogenated C 1 –C 4 alkyl, or halogenated C 1 –C 4 alkoxy, wherein at least one of R1, R3, and R5 is nitro; R6 is H or protected or unprotected side chain of natural or unnatural α-amino acid; and B is a natural or unnatural nucleobase, wherein when said nucleobase has an exocyclic amino function, said function is protected by protecting group which is labile to acids but stable to weak to medium bases.

    专利号:KR-20030084444-A
    优先权日:2002-04-26
    标 题 :A Novel Monomer For Synthesis of PNA Oligomer And A Process For Producing The Same

    专利号:US-6133444-A
    优先权日:1993-12-22
    标 题 :Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题: Pna Monomer And Precursor Monomere Et Precurseur Pna
    摘要:This Application Relates To Monomers Of The General Formula (I) For The Preparation Pna (Peptide Nucleic Acid) Oligomers And Provides Method For The Synthesis Of Both Predefined Sequence Pna Oligomers And Random Sequence Pna Oligomers: (I) Wherein E Is Nitrogen Or C-R'; J Is Sulfur Or Oxygen; R', Rl, R2, R3, R4 Is Independently H, Halogen, Alkyl, Nitro, Nitrile, Alkoxy, Halogenated Alkyl, Halogenated Alkoxy, Phenyl Or Halogenated Phenyl, Rs Is H Or Protected Or Unprotected Side Chain Of Natural Or Unnatural A-Amino Acid; And B Is A Natural Or Unnatural Nucleobase, Wherein When Said Nucleobase Has An Exocyclic Amino Function, Said Function Is Protected By Protecting Group Which Is Labile To Acids But Stable To Weak To Medium Bases In The Presence Of Thiol.

    合成参考文献


    参考文献:10.1002/cmdc.200700045
    摘要:Adebambo K, Zanoli S, Thomas M, Cancio R, Howarth N, Maga G. N2‐Benzyloxycarbonylguan‐9‐yl Acetic Acid Derivatives as HIV‐1 Reverse Transcriptase Non‐Nucleoside Inhibitors with Decreased Loss of Potency Against Common Drug‐Resistance Mutations. ChemMedChem. 2007 Sep 26;2(10):1405–9. doi: 10.1002/cmdc.200700045.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知